Investors applauded Celgene Corp.’s fourth stock split in the last 14 years on Thursday by boosting shares of the biotechnology company by nearly $5. Celgene /quotes/zigman/69584/delayed /quotes/nls/celg CELG will do a 2-for-1 …
“We expect recent increased nervousness on Celgene stock to prevail given various sell-side and bearish commentary has picked up,” Jefferies analyst Michael Yee wrote in a note.
10/27 SWING TRADE ALERT: Recent $CELG technical alerts: New 52 Week Closing Low plu.. 10/27 Expedia $EXPE, Celgene $CELG and Chipotle $CMG top the list of biggest losers.. 10/27 $CELG sheds more SUNBEAM on …
Shares of the Celgene Corporation rose 5.9 percent yesterday after regulators approved the company's Revlimid capsule for a rare blood cancer, a treatment that will cost pharmacies $215 to $225 a pill. The Food and Drug Administration …
(Reuters) - Shares of OncoMed Pharmaceuticals Inc more than doubled on Tuesday after the biotechnology company said Celgene Corp would help it develop and market six of its experimental anti-cancer stem cell drugs. OncoMed will get …
U.S. biotechnology company Celgene Corp has agreed to acquire Abraxis BioScience Inc , which makes an innovative chemotherapy treatment, for $2.9 billion in cash and stock. The deal gives Celgene, which makes the blood cancer …
Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and …
Even as the S&P 500 Index (INDEXSP:.INX) reached a new high, not all equities benefited from the rising ... stock to Buy from Hold. Blackhawk Network (NASDAQ:HAWK): Shares are now Buy from Neutral at Citigroup. Its amended price …
Celgene Corporation (Nasdaq:CELG), a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases, will …
At $95.64, the stock has room to fall short-term, even if the positive trends remain in place: “Correction support” comes into play at the $89.70-$91.30 range and the long-term uptrend line comes into play at around $83. Technicians still call …